Kenya Set for New Malaria Drug Trials

22 August 2017

Kenya is among nine countries across Africa and Asia where clinical trials will be conducted for a new anti-malarial drug.

Developed by the Swiss pharmaceutical company Novartis, alongside Medicines for Malaria Venture (MMV), the new medicine - known as KAF156 - is aimed at dealing with the tough-to-treat drug-resistant malaria.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.